1.
عبدالله ن. Efficacity of Gefitinib or Erlotinib for EGFR- mutant advanced non-small cell lung carcinoma. Tuj-hlth [Internet]. 2022Jan.17 [cited 2024Mar.28];43(6):25-32. Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/11534